Switch to:
More From Other Websites
What structural reforms are required by different countries? Feb 27 2015
Merrimack Pharmaceuticals Q4 Loss Narrower Than Expected - Analyst Blog Feb 27 2015
Who Might Buy Puma Biotechnology? Feb 27 2015
Oculus Innovative Sciences No One Trick Pony With Launch of New Animal Healthcare Division Feb 27 2015
Afrezza's Initial Sales Create Buying Opportunity Feb 27 2015
7:17 am Sanofi-Aventis announces Toujeo receives positive opinion from the European Regulatory... Feb 27 2015
What You Should Know Before Watching Vice's Special About Curing Cancer Feb 26 2015
MannKind: 'Encouraged By Early Feedback' on Afrezza Launch Feb 26 2015
BioMarin's Q4 Loss Narrower than Expected, Gives 2015 View - Analyst Blog Feb 26 2015
MannKind: Nothing to See Here Feb 25 2015
MannKind Reports Narrower Y/Y Loss in Q4, Afrezza in Focus - Analyst Blog Feb 25 2015
VIVUS Q4 Loss Wider than Expected, Qsymia Disappoints - Analyst Blog Feb 25 2015
Big pharma invests big money in research and development Feb 23 2015
Lysosomal Therapeutics to use $20M to develop, test Parkinson's drug Feb 20 2015
Afrezza Will Succeed But Initial Sales Likely To Disappoint Feb 20 2015
FDA Fast-Track Should Accrete Significant Value to This Overlooked Biotech Feb 20 2015
Sales have been slower than expected. It takes time to educate the physician. Feb 20 2015
5 Tasks for Sanofi's New CEO Feb 20 2015
Genzyme's parent company names Bayer exec as its new CEO Feb 20 2015
Sanofi's new CEO Feb 19 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK